Clinical trial
RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)
NCT00443846 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00443846 |
|---|---|
| Title | RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016) |
| Official title | An Open-label, Randomised, Comparative, Multi-centre Study of the Immunogenicity and Safety of the Concomitant Use of a Live Pentavalent Rotavirus Vaccine (RotaTeq®) and a Meningococcal Group C Conjugate (MCC) Vaccine in Healthy Infants |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Meningitis, Meningococcal, Rotavirus Infections |
| Intervention type | Biological |
| Interventions | RotaTeq®, NeisVac-C® |
| Enrollment | 247 |
| Start date | Feb 13, 2007 |
| Primary completion | Sep 4, 2007 |
| Completion | Oct 23, 2007 |
| First posted | Mar 6, 2007 |
| Last update posted | Jun 20, 2018 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: